Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Non Operating Income: 2009-2024

Historic Non Operating Income for Gyre Therapeutics (GYRE) over the last 15 years, with Dec 2024 value amounting to -$1.7 million.

  • Gyre Therapeutics' Non Operating Income rose 1069.33% to $727,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$945,000, marking a year-over-year decrease of 260.69%. This contributed to the annual value of -$1.7 million for FY2024, which is 9.29% down from last year.
  • Per Gyre Therapeutics' latest filing, its Non Operating Income stood at -$1.7 million for FY2024, which was down 9.29% from -$1.5 million recorded in FY2023.
  • In the past 5 years, Gyre Therapeutics' Non Operating Income ranged from a high of -$78,000 in FY2021 and a low of -$1.7 million during FY2024.
  • Moreover, its 2-year median value for Non Operating Income was -$1.6 million (2023), whereas its average is -$1.6 million.
  • In the last 5 years, Gyre Therapeutics' Non Operating Income crashed by 133.33% in 2020 and then increased by 14.29% in 2021.
  • Gyre Therapeutics' Non Operating Income (Yearly) stood at -$91,000 in 2020, then grew by 14.29% to -$78,000 in 2021, then reached -$1.5 million in 2023, then declined by 9.29% to -$1.7 million in 2024.